Nakamura S, Yasuo N, Sekijima M
Commun Chem. 2025; 8(1):40.
PMID: 39922979
PMC: 11807120.
DOI: 10.1038/s42004-025-01437-x.
Harb H, Elliott S, Ward L, Foster I, Klippenstein S, Curtiss L
Sci Data. 2025; 12(1):171.
PMID: 39881140
PMC: 11779890.
DOI: 10.1038/s41597-025-04468-0.
Nippa D, Muller A, Atz K, Konrad D, Grether U, Martin R
Mol Inform. 2025; 44(1):e202400361.
PMID: 39846425
PMC: 11755691.
DOI: 10.1002/minf.202400361.
Cho H, No K, Lim H
Int J Mol Sci. 2025; 26(1.
PMID: 39796080
PMC: 11720423.
DOI: 10.3390/ijms26010224.
Unsal V, Oner E, Yildiz R, Mert B
BMC Chem. 2025; 19(1):4.
PMID: 39755645
PMC: 11700471.
DOI: 10.1186/s13065-024-01371-4.
Analog Accessibility Score (AAscore) for Rational Compound Selection.
Ue T, Sato A, Miyao T
J Chem Inf Model. 2024; 64(24):9350-9360.
PMID: 39639743
PMC: 11686423.
DOI: 10.1021/acs.jcim.4c01691.
ClickGen: Directed exploration of synthesizable chemical space via modular reactions and reinforcement learning.
Wang M, Li S, Wang J, Zhang O, Du H, Jiang D
Nat Commun. 2024; 15(1):10127.
PMID: 39578485
PMC: 11584676.
DOI: 10.1038/s41467-024-54456-y.
Combining molecular design with semiempirical protein-ligand binding free energy calculation.
Iff M, Atz K, Isert C, Pachon-Angona I, Cotos L, Hilleke M
RSC Adv. 2024; 14(50):37035-37044.
PMID: 39569121
PMC: 11577348.
DOI: 10.1039/d4ra05422a.
Navigating the complexity of p53-DNA binding: implications for cancer therapy.
Thayer K, Stetson S, Caballero F, Chiu C, Han I
Biophys Rev. 2024; 16(4):479-496.
PMID: 39309126
PMC: 11415564.
DOI: 10.1007/s12551-024-01207-4.
Open Source Code Contributions to Global Health: The Case of Antimalarial Drug Discovery.
Turon G, Tse E, Qiu X, Todd M, Duran-Frigola M
ACS Med Chem Lett. 2024; 15(9):1645-1650.
PMID: 39291016
PMC: 11403727.
DOI: 10.1021/acsmedchemlett.4c00131.
Unleashing the potential of cell painting assays for compound activities and hazards prediction.
Odje F, Meijer D, von Coburg E, van der Hooft J, Dunst S, Medema M
Front Toxicol. 2024; 6:1401036.
PMID: 39086553
PMC: 11288911.
DOI: 10.3389/ftox.2024.1401036.
Artificial Intelligence Methods and Models for Retro-Biosynthesis: A Scoping Review.
Gricourt G, Meyer P, Duigou T, Faulon J
ACS Synth Biol. 2024; 13(8):2276-2294.
PMID: 39047143
PMC: 11334239.
DOI: 10.1021/acssynbio.4c00091.
Estimating the synthetic accessibility of molecules with building block and reaction-aware SAScore.
Chen S, Jung Y
J Cheminform. 2024; 16(1):83.
PMID: 39044299
PMC: 11267797.
DOI: 10.1186/s13321-024-00879-0.
MolScore: a scoring, evaluation and benchmarking framework for generative models in de novo drug design.
Thomas M, OBoyle N, Bender A, de Graaf C
J Cheminform. 2024; 16(1):64.
PMID: 38816825
PMC: 11141043.
DOI: 10.1186/s13321-024-00861-w.
Development of scoring-assisted generative exploration (SAGE) and its application to dual inhibitor design for acetylcholinesterase and monoamine oxidase B.
Lim H
J Cheminform. 2024; 16(1):59.
PMID: 38790018
PMC: 11127438.
DOI: 10.1186/s13321-024-00845-w.
AiZynthFinder 4.0: developments based on learnings from 3 years of industrial application.
Saigiridharan L, Hassen A, Lai H, Torren-Peraire P, Engkvist O, Genheden S
J Cheminform. 2024; 16(1):57.
PMID: 38778382
PMC: 11112899.
DOI: 10.1186/s13321-024-00860-x.
Prospective de novo drug design with deep interactome learning.
Atz K, Cotos L, Isert C, Hakansson M, Focht D, Hilleke M
Nat Commun. 2024; 15(1):3408.
PMID: 38649351
PMC: 11035696.
DOI: 10.1038/s41467-024-47613-w.
Machine Learning Empowering Drug Discovery: Applications, Opportunities and Challenges.
Qi X, Zhao Y, Qi Z, Hou S, Chen J
Molecules. 2024; 29(4).
PMID: 38398653
PMC: 10892089.
DOI: 10.3390/molecules29040903.
Molecule auto-correction to facilitate molecular design.
Kerstjens A, De Winter H
J Comput Aided Mol Des. 2024; 38(1):10.
PMID: 38363377
PMC: 10873457.
DOI: 10.1007/s10822-024-00549-1.
Artificial design of organic emitters a genetic algorithm enhanced by a deep neural network.
Nigam A, Pollice R, Friederich P, Aspuru-Guzik A
Chem Sci. 2024; 15(7):2618-2639.
PMID: 38362419
PMC: 10866360.
DOI: 10.1039/d3sc05306g.